| Alexion Pharmaceuticals | 182,5000 |
| Datum/Vrijeme | 20.07. / 22:00 |
| Promj. / Promj.(%) | - / |
| Potražnja | - |
| Ponuda | - |
| Otvaranje | 181,0400 |
| Prethodno zatvaranje | 179,4500 |
| Najviša cijena | 182,6700 |
| Najniža | 180,1300 |
| Volumen [USD] | 10.252.505.196,9820 |
| Volumen [Jedinice] | 90.506.123 |
| Zaključenja cijena | 89379 |
| ISIN | US0153511094 |
| Simbol | ALXN |
| Burza | NASDAQ |
| Vrsta | Stock |
Druge burze
| Burza | Posljednji | Volumen | |
|---|---|---|---|
| NASDAQ | 182,5000 | 90.506.123 | |
| Cboe US | 182,31 | 1.495.777 | |
| IEX | 183,08 | 965.183 | |
| Lang & Schwa.. | 153,84 | ||
| Quotrix | 152,9400 |
Vijesti
- DICE Therapeutics Expands Management Team and Board of Directors
28.03.2022 / 22:05 - GlobeNewswire - Fortress Biotech Reports Record 2021 Financial Results and Recent Corporate Highlights
28.03.2022 / 14:00 - GlobeNewswire - Inozyme Pharma Reports Full Year 2021 Financial Results and Provides Business Highlights
15.03.2022 / 22:24 - GlobeNewswire - Epygenix Therapeutics Announces Appointment of Darren Cline as CEO
15.03.2022 / 12:00 - GlobeNewswire - Correction: Zealand Pharma: Significant Advancement of Clinical Pipeline and Building Commercial Momentum. Key Data for Glepaglutide and Dasiglucagon Programs Expected in 2022.
11.03.2022 / 17:08 - GlobeNewswire
u realnom vremenu